These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21183561)

  • 1. Systemic lupus erythematosus following vaccination against 2009 influenza A (H1N1).
    Morihara K; Arakawa Y; Takenaka H; Morihara T; Katoh N
    Lupus; 2011 Jun; 20(7):775-6. PubMed ID: 21183561
    [No Abstract]   [Full Text] [Related]  

  • 2. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.
    Lu CC; Wang YC; Lai JH; Lee TS; Lin HT; Chang DM
    Vaccine; 2011 Jan; 29(3):444-50. PubMed ID: 21078406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.
    Urowitz MB; Anton A; Ibanez D; Gladman DD
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1517-20. PubMed ID: 22034113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus.
    Tarján P; Sipka S; Lakos G; Kiss E; Ujj G; Szegedi G
    Scand J Rheumatol; 2006; 35(3):241-3. PubMed ID: 16766374
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
    Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
    Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
    Holvast A; Huckriede A; Wilschut J; Horst G; De Vries JJ; Benne CA; Kallenberg CG; Bijl M
    Ann Rheum Dis; 2006 Jul; 65(7):913-8. PubMed ID: 16322083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.
    Park SW; Lee JH; Kim ES; Kwak YG; Moon CS; Yeom JS; Lee JH; Lee CS
    Am J Infect Control; 2011 Feb; 39(1):69-71. PubMed ID: 21122948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance.
    Auriel E; Regev K; Dori A; Karni A
    Muscle Nerve; 2011 Jun; 43(6):893-4. PubMed ID: 21607970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination.
    Denholm JT; Neal A; Yan B; Petty S; Knox J; French C; Marshall C
    Neurology; 2010 Dec; 75(24):2246-8. PubMed ID: 21172848
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pearls for H1N1 influenza vaccination.
    Marcotte GV
    J Allergy Clin Immunol; 2010 Apr; 125(4):951-2; author reply 952. PubMed ID: 20226509
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.
    Meyer S; Adam M; Schweiger B; Ilchmann C; Eulenburg C; Sattinger E; Runte H; Schlüter M; Deuse T; Reichenspurner H; Costard-Jäckle A
    Transplantation; 2011 May; 91(9):1031-5. PubMed ID: 21358365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse of nephrotic syndrome following the use of 2009 pandemic influenza A (H1N1) vaccine.
    Fernandes P; Jorge S; Lopes JA
    Am J Kidney Dis; 2010 Jul; 56(1):185-6. PubMed ID: 20620684
    [No Abstract]   [Full Text] [Related]  

  • 13. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenecity issues.
    Abu-Shakra M; Press J; Buskila D; Sukenik S
    Autoimmun Rev; 2007 Sep; 6(8):543-6. PubMed ID: 17854746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pandemic 2009 influenza H1N1 virus vaccination: compliance and safety in a single hemodialysis center.
    Stavroulopoulos A; Stamogiannos G; Aresti V
    Ren Fail; 2010; 32(9):1044-8. PubMed ID: 20863207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.
    Salmon DA; Akhtar A; Mergler MJ; Vannice KS; Izurieta H; Ball R; Lee GM; Vellozzi C; Garman P; Cunningham F; Gellin B; Koh H; Lurie N;
    Pediatrics; 2011 May; 127 Suppl 1():S78-86. PubMed ID: 21502251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of influenza vaccination: Risk-benefit evaluation.
    Wiwanitkit V
    Muscle Nerve; 2010 Aug; 42(2):296; author reply 296. PubMed ID: 20544931
    [No Abstract]   [Full Text] [Related]  

  • 17. AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.
    Roman F; Vaman T; Kafeja F; Hanon E; Van Damme P
    Clin Infect Dis; 2010 Sep; 51(6):668-77. PubMed ID: 20687838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects following pandemic influenza (H1N1) 2009 vaccination.
    Bolam B; Grills N
    Aust N Z J Public Health; 2009 Dec; 33(6):584. PubMed ID: 20078579
    [No Abstract]   [Full Text] [Related]  

  • 19. Acceptance of seasonal and pandemic a (H1N1) 2009 influenza vaccination by healthcare workers in a french teaching hospital.
    Tanguy M; Boyeau C; Pean S; Marijon E; Delhumeau A; Fanello S
    Vaccine; 2011 Jun; 29(25):4190-4. PubMed ID: 21497636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of fatal adverse events after H1N1 influenza vaccination.
    Nakada H; Narimatsu H; Tsubokura M; Murashige N; Matsumura T; Kodama Y; Kishi Y; Kami M
    Clin Infect Dis; 2010 Jun; 50(11):1548-9. PubMed ID: 20433361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.